ÀϹݿ¬Á¦ : »ý½Ä³»ºÐºñÇÐ |
- ÀϽà : 2017³â 9¿ù 22ÀÏ (±Ý)
- Àå¼Ò : ÄÁº¥¼ÇȦ A[4F] |
RE1-RE5 (08:20~09:10) |
ÁÂÀå : ½ÅÁ¤È£(°í·ÁÀÇ´ë) |
RE108:20~08:30 |
À°Áø¼º â¿ø°æ»ó´ëº´¿ø »êºÎÀΰú |
Endometriosis is related to benign breast disease, cystitis and non-toxic goiter: A 7-year
Population-based Machine Learning Approach in South Korea. |
RE208:30~08:40 |
Á¤¼±È ¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú |
Symptom-alleviating effect and adverse effect of dienogest in Korean women with
endometriosis |
RE308:40~08:50 |
Á¤¿¹¿ø Ãæ³²´ëÇб³º´¿ø »êºÎÀΰú |
To compare the efficacy of diegnogest and levonorgestrel-releasing intrauterine devices after laparoscopic surgery for endometriosis |
RE408:50~09:00 |
ÀÌÀºÇý ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Oxidative stress and HMGB-1 increases inflammatory cytokines and cell proliferation in ectopic endometrium |
RE509:00~09:10 |
±è¹ÌÁø ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
The reduction of B cell translocation gene 1 (BTG1) expression in endometrial tissues with endometriosis |
RE6-RE10 (09:10~10:00) |
ÁÂÀå : ±è¼®Çö(¼¿ïÀÇ´ë) |
RE609:10~09:20 |
È«¼Ò¿¬ Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú |
Association of genetic polymorphisms in vascular endothelial growth factor gene (VEGF
-460, -7, and -583) and hematocrit level with the development of idiopathic recurrent
pregnancy loss |
RE709:20~09:30 |
Á¤Çý°æ ¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú |
Interleukin-10 gene polymorphisms in Korean patients with polycystic ovary syndrome |
RE809:30~09:40 |
ÀÓÁ¤¹Ì °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Expression of Müllerian inhibiting substance receptor and antiproliferative effects of MIS on human adenomyosis tissue |
RE909:40~09:50 |
±èÁ¤¼÷ ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú |
Abnormal vasopressin secretion without osmotic stimulation after chronic salt loading of rat
; Possible mechanism of SIADH
|
RE1009:50~10:00 |
À̼±ÀÇ °¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø »êºÎÀΰú |
Parity and increased risk of insulin resistance in postmenopausal
women: the 2010 Korean National Health and Nutrition
Examination Survey |
RE11-RE13 (14:00~14:30) |
ÁÂÀå : ¹ÚÂù¿ì(´Ü±¹ÀÇ´ë) |
RE1114:00~14:10 |
±è¼¼Á¤ ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Optimal number of oocytes in controlled ovarian stimulation with GnRH antagonist |
RE1214:10~14:20 |
±èÇϽŠ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Increasing the dose of follicle-stimulating hormone on day of gonadotropin-releasing hormone antagonist administration for controlled ovarian hyperstimulation |
RE1314:20~14:30 |
±è¼º¿ì ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
The usefulness of Intracytoplasmic sperm injection (ICSI) as a routine procedure in non-male
factor infertility for patients with three or fewer oocytes retrieved |
RE14-RE16 (14:30~15:00) |
ÁÂÀå : ±è¼ºÈÆ(¿ï»êÀÇ´ë) |
RE1414:30~14:40 |
ÀÌÁøÁÖ °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Estimation of the prevalence and incidence of endometriosis with administrative data in Korean Women: A National Population-based Study |
RE1514:40~14:50 |
¹ÚÁ¤À± °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú |
Epidemiology and Recent Treatment Trends of Uterine Leiomyoma in Korean Women: A
National Population-based Study |
RE1614:50~15:00 |
ÇѼöÁø ¼¿ï´ëÇб³º´¿ø »êºÎÀΰú |
Differences between Ovulatory and Anovulatory PCOS |